These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36285390)

  • 21. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results.
    Dell'Amore A; Monteverde M; Martucci N; Sanna S; Caroli G; Dolci G; Dell'Amore D; Rocco G
    Gen Thorac Cardiovasc Surg; 2015 Apr; 63(4):222-30. PubMed ID: 25403998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
    Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
    Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
    Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
    Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
    BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
    Rinewalt D; Shersher DD; Daly S; Fhied C; Basu S; Mahon B; Hong E; Chmielewski G; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1344-50; discussion 1350-1. PubMed ID: 22982029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
    Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
    Wong ML; McMurry TL; Stukenborg GJ; Francescatti AB; Amato-Martz C; Schumacher JR; Chang GJ; Greenberg CC; Winchester DP; McKellar DP; Walter LC; Kozower BD
    Lung Cancer; 2016 Dec; 102():108-117. PubMed ID: 27987578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Lee SC; Chang H
    J Chin Med Assoc; 2014 Aug; 77(8):416-21. PubMed ID: 25028298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
    Watanabe K; Tsuboi M; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ando K; Ishikawa Y; Woo T; Adachi H; Kumakiri Y; Maehara T; Nakayama H; Masuda M
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1624-31. PubMed ID: 26792922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
    Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
    Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
    Lai WW; Wu MH; Yan JJ; Chen FF
    Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.
    Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M
    Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):166-72. PubMed ID: 23143203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-small cell lung cancer: disease spectrum and management in a tertiary care hospital.
    Khan MR; Hasan SB; Sami SA
    J Pak Med Assoc; 2000 Oct; 50(10):330-3. PubMed ID: 11109751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
    Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
    Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada.
    Sara Kuruvilla M; Liu G; Syed I; Gwadry-Sridhar F; Sheffield BS; Sachdeva R; Pencz A; Zhan L; Hueniken K; Patel D; Balaratnam K; Khan K; Grant B; Noy S; Singh K; Liu L; Rakibuz-Zaman M; Moldaver D; Kate Shanahan M; Cheema PK
    Lung Cancer; 2022 Nov; 173():58-66. PubMed ID: 36152478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.